Alibaba Group Holding Limited (BABA) saw its stock rise in premarket trading after receiving a clean bill of health from Chinese regulators following a three-year investigation. The company was penalized in 2021 for monopolistic practices but has since addressed the concerns, leading to the positive regulatory outcome. Analysts are optimistic about Alibaba’s future, with an average price target suggesting potential upside.